Prostate Carcinoma
Conditions
Brief summary
This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab set up at the individual and community levels. Cancer is the second leading cause of death for Black men and Black men are less likely to receive prostate cancer screening. CoLLab Learning Health System utilizes community health workers (CHW) that are well-trained to form a bridge between communities and clinicians. In fact, Black men who work with CHW's typically have better access to health services, gain knowledge about cancer, cancer prevention, treatment and may have better overall health outcomes. Establishing a CoLLab Learning Health System at American Legion Posts may improve access to clinical trials and prostate cancer services in Black men.
Detailed description
PRIMARY OBJECTIVES: I. Co-create real-life user centric CoLLab Learning Health System at three American Legion Posts, compared to an American Legion Post with no CoLLab set-up. American Legion Post 197 will serve as the hub and Post 244 and Post 194 as the spokes. II. Assess and evaluate the impact of the CoLLab Learning Health Systems compared to the comparison Post at the individual and community levels. III. Explore the feasibility of replicating the CoLLab Learning Health System in Black communities nationally. OUTLINE: Participants access CoLLab Learning Health System to use any of the services at least twice monthly for up to 1 year.
Interventions
Access CoLLab Learning Health System to use any of the services
OTHERQuestionnaire Administration
Ancillary studies
Sponsors
Mayo Clinic
Congressionally Directed Medical Research Programs
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* AIMS 1 AND 3: Participants must be one of the following key personnel: * Community PI (n=1), * CoLLab Program Manager (n=1) * CoLLab Site Managers (n=3) * CoLLab CAB members (n=21) * 2 Community Health Workers (CHWs) per Post site (n=6) * AIMS 1 AND 3: Between the ages of 21 and 80. * AIMS 1 AND 3: Able to complete the survey in English. * AIMS 1 AND 3: Reside in the Jacksonville, FL and/or surrounding counties. * AIMS 1 AND 3: Willing and able to consent to the study. * AIM 2: Black adult of any gender. * AIM 2: Must be between the ages of 30 and 80. * AIM 2: Able to speak English. * AIM 2: Reside in the Jacksonville, FL and/or surrounding counties. * AIM 2: Willing and able to consent to the study.
Exclusion criteria
* AIMS 1 AND 3: Younger than 21years or older than 80 years. * AIMS 1 AND 3: Not a resident of NE Florida. Unwilling or unable to consent to the study. * AIM 2: Younger than 30 years or older than 80 years. * AIM 2: Not a resident of NE Florida. * AIM 2: Unwilling or unable to consent to the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Create real-life user centric CoLLab Learning Health System (program production) | Up to 12 months | Qualitative data collection will be employed during a town hall meeting with the CoLLab Community Advisory Board (CAB) to ensure that we get unbiased and objective feedback from participants. |
| Impact of the CoLLab Learning Health Systems | Baseline; up to 12 months | Will be assessed using pre-test and post-test survey scores from a Prostate Health Resources Questionnaire, which consists of 6 multiple choice questions, 8 true/false/don't know questions, 13 questions answered on a 5-point scale (e.g., very favorable to unfavorable or strongly agree to strongly disagree), and 20 yes/no questions. |
| Feasibility of Replication - cost analysis | Up to 24 months | Will be assessed using cost analysis of direct and indirect costs. |
| Feasibility of Replication - qualitative | Up to 24 months | Will be assessed qualitatively based on interviews of key personnel and users |
Countries
United States
Contacts
CONTACTClinical Trials Referral Office
CONTACTQuincy Wimberly
PRINCIPAL_INVESTIGATORFolakemi T. Odedina, Ph.D.
Mayo Clinic
Outcome results
None listed